Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).

Véronique PhéMarc P SchneiderBenoit PeyronnetNadim Abo YoussefLivio MordasiniEmmanuel Chartier-KastlerLucas M BachmannThomas M M Kessler

Published in: Neurourology and urodynamics (2017)

Preliminary data suggest that intravesical vanilloids might be effective for treating NLUTD in patients with MS. However, the safety profile seems unfavorable, the overall quality of evidence is low and no licensed substance is currently available warranting well-designed, adequately sampled and properly powered RCTs.

Keyphrases

urinary tract
mass spectrometry
spinal cord injury
multiple sclerosis
electronic health record
robot assisted
ms ms
oxidative stress
big data
machine learning
deep learning
minimally invasive